Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 30Observational 3

Sponsor

Cancer Type

Gastrointestinal 2

Conditions

Carcinoma, Hepatocellular 2HCC 1

Interventions

Surveys and Questionnaires 543Blood Specimen Collection 446Surgical Procedures, Operative 164Observation 152Drug Therapy 142Radiotherapy 141Interviews as Topic 139Gene Expression Profiling 129Biopsy 117Magnetic Resonance Spectroscopy 116Immunohistochemistry 112Data Collection 95Polymerase Chain Reaction 87Specimen Handling 81Amplified Fragment Length Polymorphism Analysis 81Bevacizumab 78Microarray Analysis 76Flow Cytometry 69Neoadjuvant Therapy 68Watchful Waiting 66Magnetic Resonance Imaging 65Immune Checkpoint Inhibitors 61Nivolumab 60Immunotherapy 57Therapeutics 55Reverse Transcriptase Polymerase Chain Reaction 52pembrolizumab 50Ultrasonography 47Positron Emission Tomography Computed Tomography 47Hematologic Tests 46

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Observational × Ethiodized Oil × Clear all
NCT04459468 2026-01-08

Identify Proteomic Biomarkers for Outcome Prediction of Locoregional Treatments for HCC

University of Texas Southwestern Medical Center

Completed
17 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT05291338 2023-07-28

Pharmacogenetic Study in Hepatocellular Carcinoma Patients.

Damanhour University

Completed
107 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT03108248 2017-04-11

ISP-TACE Versus TACE for HCC With PVTT

Zhongda Hospital

Completed
126 enrolled

HCC

Data powered by HemOnc (CC BY 4.0) Colophon âš¡